AAAAAA
Results:
1-7
|
Results: 7
Authors:
Schwob, JE
Saha, S
Youngentob, SL
Jubelt, B
Citation: Je. Schwob et al., Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice, CHEM SENSE, 26(8), 2001, pp. 937-952
Authors:
Youngentob, SL
Schwob, JE
Saha, S
Manglapus, G
Jubelt, B
Citation: Sl. Youngentob et al., Functional consequences following infection of the olfactory system by intranasal infusion of the olfactory bulb line variant (OBLV) of mouse hepatitis strain JHM, CHEM SENSE, 26(8), 2001, pp. 953-963
Authors:
Jubelt, B
Berger, JR
Citation: B. Jubelt et Jr. Berger, Does viral disease underlie ALS? Lessons from the AIDS pandemic, NEUROLOGY, 57(6), 2001, pp. 945-946
Authors:
Trojan, DA
Collet, JP
Pollak, MN
Shapiro, S
Jubelt, B
Miller, RG
Agre, JC
Munsat, TL
Hollander, D
Tandan, R
Robinson, A
Finch, L
Ducruet, T
Cashman, NR
Citation: Da. Trojan et al., Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome, J NEUR SCI, 182(2), 2001, pp. 107-115
Authors:
Jubelt, B
Agre, JC
Citation: B. Jubelt et Jc. Agre, Characteristics and management of postpolio syndrome, J AM MED A, 284(4), 2000, pp. 412-414
Authors:
Trojan, DA
Collet, JP
Shapiro, S
Jubelt, B
Miller, RG
Agre, JC
Munsat, TL
Hollander, D
Tandan, R
Granger, C
Robinson, A
Finch, L
Ducruet, T
Cashman, NR
Citation: Da. Trojan et al., A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome - Reply, NEUROLOGY, 55(6), 2000, pp. 900-901
Authors:
Trojan, DA
Collet, JP
Shapiro, S
Jubelt, B
Miller, RG
Agre, JC
Munsat, TL
Hollander, D
Tandan, R
Granger, C
Robinson, A
Finch, L
Ducruet, T
Cashman, NR
Citation: Da. Trojan et al., A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome, NEUROLOGY, 53(6), 1999, pp. 1225-1233
Risultati:
1-7
|